Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Medical Specialties
symbol | company | %chng | last | %short | avg$volume | |
---|---|---|---|---|---|---|
TMO | Thermo Fisher Scientific, Inc. | 1.35% | 503.64 | 1.0% | $786.25m | |
DHR | Danaher Corp. | 0.06% | 236.84 | 0.7% | $559.35m | |
ABT | Abbott Laboratories | 1.15% | 111.31 | 0.8% | $479.43m | |
MDT | Medtronic Plc | -0.82% | 116.80 | 0.6% | $436.93m | |
ISRG | Intuitive Surgical, Inc. | -2.35% | 778.42 | 2.3% | $410.96m | |
BSX | Boston Scientific Corp. | 0.44% | 36.32 | 1.0% | $374.11m | |
DXCM | DexCom, Inc. | 0.60% | 354.20 | 7.8% | $327.46m | |
BDX | Becton, Dickinson & Co. | 1.58% | 261.84 | 1.0% | $304.15m | |
SYK | Stryker Corp. | 0.02% | 242.18 | 1.3% | $235.44m | |
ALGN | Align Technology, Inc. | 2.27% | 567.23 | 6.4% | $223.44m | |
A | Agilent Technologies, Inc. | 0.17% | 126.24 | 1.6% | $213.98m | |
QDEL | Quidel Corp. | 3.26% | 204.49 | 7.7% | $192.34m | |
EW | Edwards Lifesciences Corp. | 0.39% | 87.83 | 0.4% | $191.59m | |
BAX | Baxter International, Inc. | 0.00% | 80.05 | 1.8% | $185.95m | |
IDXX | IDEXX Laboratories, Inc. | 0.12% | 489.46 | 3.8% | $176.70m |
Company Profile
Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.